scispace - formally typeset
J

Josune García-Sanmartín

Researcher at Spanish National Research Council

Publications -  21
Citations -  262

Josune García-Sanmartín is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Adrenomedullin & Calcitonin gene-related peptide. The author has an hindex of 7, co-authored 21 publications receiving 173 citations.

Papers
More filters
Journal ArticleDOI

Adrenomedullin and tumour microenvironment

TL;DR: AM is a great target for drug development and new drugs interfering with this system are being developed since AM acts as an autocrine/paracrine growth factor, increases tumour cell motility and metastasis, induces angiogenesis, and blocks immunosurveillance by inhibiting the immune system.
Journal ArticleDOI

Bioactive bilayered dressing for compromised epidermal tissue regeneration with sequential activity of complementary agents

TL;DR: Application of the bilayered dressing in the wound healing rabbit ear model shows an improved cicatrization of the wound in both ischemic and non-ischemic defects, favoring epithelialization and reducing noticeably the contraction and the inflammation.
Journal ArticleDOI

Potent “Clicked” MMP2 Inhibitors: Synthesis, Molecular Modeling and Biological Exploration

TL;DR: A new series of MMP2 inhibitors is described, following a fragment-based drug design approach, and one fragment containing an azide group and a well known hydroxamate Zinc Binding Group in a α-sulfone, α-tetrahydropyrane scaffold has been synthesized.
Journal ArticleDOI

Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients

TL;DR: In this paper, the authors explored the behavior of calcitonin gene-related peptide (CGRP), an angiogenic, vasodilating, and immune modulating peptide, in severe acute respiratory syndrome coronavirus 2 positive patients.
Journal ArticleDOI

Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer

TL;DR: It is suggested that treatment with AM or with positive modulator SMs may represent a novel strategy for colon cancer.